These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11578108)

  • 21. Oral absorption of D-oligopeptides in rats via the paracellular route.
    He YL; Murby S; Gifford L; Collett A; Warhurst G; Douglas KT; Rowland M; Ayrton J
    Pharm Res; 1996 Nov; 13(11):1673-8. PubMed ID: 8956333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
    Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Cardiologia; 1997 Nov; 42(11):1165-72. PubMed ID: 9534309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
    Yu H; Kim K
    Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One dose of oral hexarelin protects chronic cardiac function after myocardial infarction.
    Mao Y; Tokudome T; Kishimoto I; Otani K; Miyazato M; Kangawa K
    Peptides; 2014 Jun; 56():156-62. PubMed ID: 24747279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of oral absorption of panaxnotoginseng saponins].
    Han M; Han LM; Wang QS; Bai ZH; Fang XL
    Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
    Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
    Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.
    Roumi M; Lenaerts V; Boutignon F; Wuthrich P; Deghenghi R; Bellemare M; Adam A; Ong H
    Peptides; 1995; 16(7):1301-6. PubMed ID: 8545255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man.
    Arvat E; Gianotti L; Ramunni J; DiVito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Jan; 19(1):25-9. PubMed ID: 8851688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone status during long-term hexarelin therapy.
    Rahim A; O'Neill PA; Shalet SM
    J Clin Endocrinol Metab; 1998 May; 83(5):1644-9. PubMed ID: 9589671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro/in vivo models for peptide oral absorption: comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides.
    Conradi RA; Wilkinson KF; Rush BD; Hilgers AR; Ruwart MJ; Burton PS
    Pharm Res; 1993 Dec; 10(12):1790-2. PubMed ID: 8302767
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
    Varma MV; Panchagnula R
    Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
    Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
    Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.
    Kim SK; Lee DY; Lee E; Lee YK; Kim CY; Moon HT; Byun Y
    J Control Release; 2007 Jul; 120(1-2):4-10. PubMed ID: 17490773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death.
    Filigheddu N; Fubini A; Baldanzi G; Cutrupi S; Ghè C; Catapano F; Broglio F; Bosia A; Papotti M; Muccioli G; Ghigo E; Deghenghi R; Graziani A
    Endocrine; 2001 Feb; 14(1):113-9. PubMed ID: 11322493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
    Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
    Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of effect of hexarelin on TRH-induced TSH response in normal adult man.
    Arosio M; Casati G; Biella O; Porretti S; Imbimbo BP; Faglia G
    J Endocrinol Invest; 1998 Apr; 21(4):239-44. PubMed ID: 9624598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.